Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosisReport as inadecuate




Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis - Download this document for free, or read online. Document in PDF available to download.

Journal of Neuroinflammation

, 14:148

First Online: 24 July 2017Received: 08 February 2017Accepted: 14 July 2017

Abstract

BackgroundMP4-induced experimental autoimmune encephalomyelitis EAE is a mouse model of multiple sclerosis MS, which enables targeted research on B cells, currently much discussed protagonists in MS pathogenesis. Here, we used this model to study the impact of the S1P1 receptor modulator FTY720 fingolimod on the autoreactive B cell and antibody response both in the periphery and the central nervous system CNS.

MethodsMP4-immunized mice were treated orally with FTY720 for 30 days at the peak of disease or 50 days after EAE onset. The subsequent disease course was monitored and the MP4-specific B cell-antibody response was measured by ELISPOT and ELISA. RNA sequencing was performed to determine any effects on B cell-relevant gene expression. S1P1 receptor expression by peripheral T and B cells, B cell subset distribution in the spleen and B cell infiltration into the CNS were studied by flow cytometry. The formation of B cell aggregates and of tertiary lymphoid organs TLOs was evaluated by histology and immunohistochemistry. Potential direct effects of FTY720 on B cell aggregation were studied in vitro.

ResultsFTY720 significantly attenuated clinical EAE when treatment was initiated at the peak of EAE. While there was a significant reduction in the number of T cells in the blood after FTY720 treatment, B cells were only slightly diminished. Yet, there was evidence for the modulation of B cell receptor-mediated signaling upon FTY720 treatment. In addition, we detected a significant increase in the percentage of B220 B cells in the spleen both in acute and chronic EAE. Whereas acute treatment completely abrogated B cell aggregate formation in the CNS, the numbers of infiltrating B cells and plasma cells were comparable between vehicle- and FTY720-treated mice. In addition, there was no effect on already developed aggregates in chronic EAE. In vitro B cell aggregation assays suggested the absence of a direct effect of FTY720 on B cell aggregation. However, FTY720 impacted the evolution of B cell aggregates into TLOs.

ConclusionsThe data suggest differential effects of FTY720 on the B cell compartment in MP4-induced EAE.

KeywordsB cells EAE Fingolimod FTY720 Multiple sclerosis TLO AbbreviationsB6C57BL-6

BBBBlood-brain-barrier

BCRB cell receptor

BWBody weight

CNSCentral nervous system

CSFCerebrospinal fluid

CXCL13Chemokine ligand 13

DABDiaminobenzidine

DEGDifferentially expressed gene

EAEExperimental autoimmune encephalomyelitis

FDCFollicular dendritic cell

HEHematoxylin and eosin

HEVHigh endothelial venule

IgImmunglobulin

LPSLipopolysaccharide

IL-4Interleukin-4

MBPMyelin basic protein

MOGMyelin oligodendrocyte glycoprotein

MPMilk powder

MP4MBP-PLP fusion protein

MSMultiple sclerosis

OCBOligoclonal bands

PBSPhosphate-buffered saline

PFAParaformaldehyde

PLPProteolipid protein

PNAdPeripheral node addressin

RR-MSRelapsing-remitting MS

SLOSecondary lymphoid organ

SP-MSSecondary progressive MS

TLOTertiary lymphoid organ

Electronic supplementary materialThe online version of this article doi:10.1186-s12974-017-0924-4 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Kathrin Bail - Quirin Notz - Damiano M. Rovituso - Andrea Schampel - Marie Wunsch - Tobias Koeniger - Verena Schropp - Ric

Source: https://link.springer.com/







Related documents